Regeneron Pharmaceuticals | 477.1499 / +0.42% |
News
- Intellia Therapeutics Names Georgia Keresty, Ph.D., M.P.H., to Board of Directors
13:30 - GlobeNewswire - Roche: Antibody cocktail reduces symptomatic COVID infections by 81%
07:25 - TeleTrader - Ziopharm Oncology to Present Poster at American Association for Cancer Research Virtual 2021 Annual Meeting
04/07/2021 / 15:00 - GlobeNewswire - Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis
04/01/2021 / 14:00 - GlobeNewswire - Intellia Therapeutics’ Investigational CRISPR Treatment NTLA-2001 Receives European Union Orphan Drug Designation for ATTR Amyloidosis
03/30/2021 / 13:30 - GlobeNewswire - Kiniksa Announces FDA Approval of ARCALYST ® (rilonacept) for Recurrent Pericarditis
03/18/2021 / 21:30 - GlobeNewswire - Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
03/15/2021 / 07:00 - GlobeNewswire - FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
03/04/2021 / 07:00 - GlobeNewswire - EMA extends use advice for Regeneron COVID mix
02/26/2021 / 12:28 - TeleTrader - Ziopharm Oncology Provides Leadership and Corporate Updates; Reports Fourth Quarter and Full Year 2020 Financial Results
02/25/2021 / 22:05 - GlobeNewswire - Europe closes lower amid recovery uncertainties
02/25/2021 / 17:31 - TeleTrader - Regeneron: COVID cocktail has clear efficacy
02/25/2021 / 14:13 - TeleTrader - Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
02/25/2021 / 13:30 - GlobeNewswire - Decibel Therapeutics Presents Promising Preclinical Findings on DB-OTO, Gene Therapy Product Candidate Designed to Provide Hearing to Individuals with Otoferlin Mutations
02/24/2021 / 13:00 - GlobeNewswire - Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity
02/23/2021 / 14:00 - GlobeNewswire